Trupanion
TRUP
35.56
-0.31
-0.86%
Trupanion
US · TRUP
#3196 by market cap
35.56
-0.31
-0.86%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:30
✦ Quant Ownership Signal how this is computed
Accumulating
- Total institutional ownership rose 1.1 percentage points.
Ownership vs. money flow
AlignedInstitutions added shares last reporting period, and the stock has seen net inflows in main-fund flow over the last 20 trading sessions - the two line up.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Institutional ownership
- Held by institutions
- 94.87% +1.11pp
- Institutions
- 256
- As of
- 2026/Q3 vs. prior period
Holder types
Mutual Fund60.63%
Public Company14.92%
Private Company10.57%
Hedge Fund7.12%
Individual/Insider5.62%
Government Pension Fund1.00%
Insurance Company0.32%
Family Office/Trust0.25%
Other0.66%
Top holders as of 2026-09-30
BlackRock
13.19% · 5.71M sh
Felix Holdings B.V.
9.93% · 4.30M sh
Aflac Incorporated
8.40% · 3.64M sh
Nielsen Capital Management Fondsmaeglerselskab A/S
6.71% · 2.90M sh
Capital Research
4.97% · 2.15M sh
FMR
4.49% · 1.94M sh
Vanguard Portfolio Management, LLC
4.13% · 1.79M sh
Polar Capital Holdings Plc
4.04% · 1.75M sh
Vanguard Capital Management, LLC
3.45% · 1.49M sh
Darryl Graham Rawlings
3.38% · 1.46M sh
State Street Global Advisors
3.11% · 1.37M sh
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 19 buys · 31 sells
| Name | Role | Stake |
|---|---|---|
| Darryl Graham Rawlings | Founder & Chair of the Board | 3.38% |
| Howard Rubin | Independent Director | 0.54% |
| Margaret Rosemary Tooth | Chief Executive Officer | 0.43% |
| Murray Low | Lead Independent Director | 0.36% |
| Steve Weinrauch | Chief Veterinary & Product Officer | 0.19% |
| Asher Bearman | Chief Legal Officer | 0.17% |
| Emily Dreyer | Former Chief Revenue Officer | 0.08% |
| John Gallagher | Chief Operating Officer | 0.08% |
| Simon Wheeler | Executive Vice President of International Business | 0.06% |
| Jacqueline Davidson | Independent Director | 0.04% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-11-09 | Murray Low | Lead Independent Director | Open Market Disposition | -6,537 | $34.21 |
| 2026-11-08 | Howard Rubin | Independent Director | Open Market Disposition | -30,000 | $35.23 |
| 2026-11-08 | Margaret Rosemary Tooth | Chief Executive Officer | Automatic Disposition | -2,000 | $36.44–36.92 |
| 2026-10-27 | John Gallagher | Chief Operating Officer | Automatic Disposition | -431 | $29.12 |
| 2026-10-08 | Margaret Rosemary Tooth | Chief Executive Officer | Automatic Disposition | -1,000 | $25.84 |
| 2026-09-27 | John Gallagher | Chief Operating Officer | Automatic Disposition | -431 | $22.92 |
| 2026-09-10 | Margaret Rosemary Tooth | Chief Executive Officer | Automatic Disposition | -1,000 | $25.00 |
| 2026-08-27 | John Gallagher | Chief Operating Officer | Automatic Disposition | -3,604 | $29.70 |
| 2026-08-25 | Fawwad Qureshi | Chief Financial Officer | Derivative Exercise and Sale | -3,750 | $30.01–31.84 |
| 2026-08-25 | Fawwad Qureshi | Chief Financial Officer | Open Market Disposition | -3,858 | $30.01 |
| 2026-08-24 | Asher Bearman | Chief Legal Officer | Derivative Exercise and Sale | -841 | $31.76–31.84 |
| 2026-08-24 | Asher Bearman | Chief Legal Officer | Derivative Exercise and Retained | +1,769 | -- |
| 2026-08-24 | Margaret Rosemary Tooth | Chief Executive Officer | Derivative Exercise and Sale | -7,491 | $31.76–31.84 |
| 2026-08-24 | Margaret Rosemary Tooth | Chief Executive Officer | Derivative Exercise and Retained | +11,551 | -- |
| 2026-08-24 | Steve Weinrauch | Chief Veterinary & Product Officer | Derivative Exercise and Sale | -1,181 | $31.76–31.84 |
| 2026-08-24 | Steve Weinrauch | Chief Veterinary & Product Officer | Derivative Exercise and Retained | +3,678 | -- |
| 2026-08-24 | John Gallagher | Chief Operating Officer | Derivative Exercise and Sale | -1,651 | $31.76–31.84 |
| 2026-08-24 | John Gallagher | Chief Operating Officer | Derivative Exercise and Retained | +5,143 | -- |
| 2026-08-24 | Simon Wheeler | Executive Vice President of International Business | Derivative Exercise and Sale | -1,085 | $31.76–31.84 |
| 2026-08-24 | Simon Wheeler | Executive Vice President of International Business | Derivative Exercise and Retained | +1,088 | -- |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.
Trupanion discussion 0 comments